Latest filing published 19 Mar 2019 for GT Biopharma, Inc., €155.
Filing timeline
BuySaleInsider track record
Raymond W. Urbanski: trading record in brief
Raymond W. Urbanski has filed trades across 2 companies (mainly through SEC (Form 4)), most often in GT Biopharma, Inc. and Mannkind Corp. The record holds 2 filings, for trades running from 10 August 2017 to 1 February 2019.
On the market, this insider has only sold: 2 sales, €444 in total. In 2019 alone, the filings show no purchases and 1 sale.
On 19 March 2019 came the latest disclosure, an open-market sale for €155 in GT Biopharma, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Raymond W. Urbanski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 176,980 shares@ US$0.001100.0% of flowcommon stockSEC:0000939798-19-000008:0
- 296 shares@ US$1.15100.0% of flowCommon Stock,$.01 par valueSEC:0001209191-17-048662:0
2 of 2 declarations